Partnership · 14 August 2026Redcliffe LabsOmnichannel diagnostic service providerredcliffelabs.com ↗
PartnershipHealthcare & Life Sciences
Redcliffe Labs partners with Skyroot Aerospace for space diagnostics
By Abha Lohia · Editor ·
Redcliffe Labs: revenue and funding and every story →
- Redcliffe Labs is an omnichannel diagnostic service provider with labs across 220+ cities
- It has partnered with Skyroot Aerospace to test dry diagnostic reagents in Low Earth Orbit for 90 days
- The experiment could help develop diagnostic products for space missions and remote areas with limited lab infrastructure
What happened
- Redcliffe Labs and Skyroot Aerospace have partnered to test diagnostic reagents in space.
- The first experiment, named DRIFT-1, will place Redcliffe's dry diagnostic reagents in Low Earth Orbit for 90 days.
- The performance of the space-exposed reagents will be compared with an identical control sample maintained on Earth.
- The experiment aims to examine how the space environment affects reagent stability and performance.
- The initiative is expected to generate flight data for diagnostic technologies for space missions and challenging Earth environments.
- Findings could help develop diagnostic products for locations with limited lab infrastructure or cold-chain facilities.
- Potential applications include astronaut healthcare, life sciences, microgravity research, and point-of-care diagnostics for human spaceflight programmes such as Gaganyaan and Bharatiya Antariksh Station.
- The statement did not disclose the launch timeline, rocket or spacecraft, number or types of reagents, or financial terms of the partnership.
Why it matters
- Redcliffe Labs recently divested its fertility services business Crysta IVF to focus on diagnostics.
- Skyroot Aerospace conducted the first orbital rocket launch by an Indian private company in July 2026.
- The partnership could open new applications for diagnostics in space and remote areas.
The business
- Redcliffe Labs is an omnichannel diagnostic service provider offering pathology and diagnostic services through labs, collection centres, and home sample collection.
- It operates across more than 220 cities and offers over 3,600 diagnostic tests.
- The company has 80+ self-owned certified labs, 2,000+ collection centres, and 1,500+ trained phlebotomists.
- It has touched over 1 crore lives.
The founders
In numbers
220+Cities of operation
3,600+Diagnostic tests offered
1 Crore+Lives touched
80+Self-owned labs
2,000+Collection centres
1,500+Trained phlebotomists
$115 MnTotal funding raised
What happens next
- The partnership aims to generate flight data for diagnostic technologies for space missions and challenging Earth environments.
- Findings could lead to diagnostic products for locations with limited lab infrastructure or cold-chain facilities.
- Potential applications include astronaut healthcare, life sciences, microgravity research, and point-of-care diagnostics for human spaceflight programmes including Gaganyaan and Bharatiya Antariksh Station.
Earlier rounds
- September 2024 · Series C · $42 Mn · led by Denmark's Investment Fund for Developing Countries
Words to know
- Low Earth Orbit
- An orbit around Earth at an altitude between 160 and 2,000 kilometres, commonly used for satellites and the International Space Station.
- Dry diagnostic reagents
- Reagents that are stored in a dry, stable form and can be rehydrated for use, making them easier to transport and store without cold chains.
- Gaganyaan
- India's human spaceflight programme led by ISRO, aiming to send astronauts to Low Earth Orbit.
- Bharatiya Antariksh Station
- India's planned space station, expected to be operational by the 2030s.
The numbers around it
Redcliffe Labs has 4 funding rounds in StopDown's archive, $115 Mn raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 17 September 2024 | Series C | $42M | IFU (Denmark's Investment Fund for Developing Countries) |
| 13 August 2023 | growth | $80 million | |
| 29 September 2022 | Series B | $100-125 million | |
| 6 May 2022 | Series B | $61M | LeapFrog Investments |
Healthcare & Life Sciences in August 2026: 10 rounds with a disclosed amount, $139 million in all; the biggest was Biodeal Pharmaceuticals (₹385 crore). Every sector this year →
Other articles talking about it
Read next
FundingRedcliffe Lifetech raises $61 million Series BRedcliffe Lifetech is an omnichannel diagnostics platform offering 3,500+ pathology and genetic testsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Redcliffe Labs → · All startup news on 14 August 2026 →
Is this Redcliffe Labs? Get your “Featured on StopDown” badge →